Whither gene patenting and the patenting of diagnostic methods post-Mayo and Myriad? The need for certainty in navigating the high seas of policy

Whither gene patenting and the patenting of diagnostic methods post-Mayo and Myriad? The need for certainty in navigating the high seas of policy

This paper is prompted by a series of recent high-profile decisions emanating from the apex courts in the US and Australia – namely, Mayo and Myriad – on the patent eligibility of gene-based inventions. Adopting a comparative approach, this paper critically examines whether isolated gene sequences a...

Full description

Saved in:
Bibliographic Details
Main Author: SAW, Cheng Lim
Format: text
Language:English
Published: Institutional Knowledge at Singapore Management University 2016
Subjects:
Biotechnological inventions
human genetics
molecular diagnostics
public health
comparative law
patentable subject matter
patent eligibility
discovery-invention distinction
EU Biotech Directive
Intellectual Property Law
Online Access:https://ink.library.smu.edu.sg/sol_research/1821
https://ink.library.smu.edu.sg/context/sol_research/article/3773/viewcontent/Whither_Gene_Patenting_Post_Myriad__Publication_Copy___LIT_.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Singapore Management University
Language: English

Internet

https://ink.library.smu.edu.sg/sol_research/1821
https://ink.library.smu.edu.sg/context/sol_research/article/3773/viewcontent/Whither_Gene_Patenting_Post_Myriad__Publication_Copy___LIT_.pdf

Similar Items